» Articles » PMID: 17604872

High Throughput Solubility Measurement in Drug Discovery and Development

Overview
Specialty Pharmacology
Date 2007 Jul 3
PMID 17604872
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Measurement of drug solubility in various solvents is one of the key elements of compound characterization during the whole discovery and development process. This review summarizes current experimental approaches and addresses recent advances in the experimental methods used to determine drug solubility in drug discovery and early development. This paper focuses on high throughput methods designed to determine kinetic and thermodynamic (equilibrium) solubility but traditional methods are also presented. The focus, positioning, experimental setup, pros and cons, and limitations of individual assays are discussed and differences in solubility studies in discovery and development environments are highlighted. Finally, future needs and trends in solubility assay development designed to overcome current bottlenecks and trade-offs between speed and quality/quantity of measurements are addressed.

Citing Articles

Pharmaceutical Salts: Comprehensive Insights From Fundamental Chemistry to FDA Approvals (2019-2023).

Dhaval M, Dudhat K, Gadoya A, Shah S, Pethani T, Jambukiya N AAPS PharmSciTech. 2025; 26(1):36.

PMID: 39821716 DOI: 10.1208/s12249-024-03020-4.


Towards the prediction of drug solubility in binary solvent mixtures at various temperatures using machine learning.

Bao Z, Tom G, Cheng A, Watchorn J, Aspuru-Guzik A, Allen C J Cheminform. 2024; 16(1):117.

PMID: 39468626 PMC: 11520512. DOI: 10.1186/s13321-024-00911-3.


Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.

Aldhafiri W, Chhonker Y, Ahmed N, Singh S, Haney S, Ford J Molecules. 2024; 29(18).

PMID: 39339419 PMC: 11434026. DOI: 10.3390/molecules29184424.


Biopharmaceutical profiling of anti-infective sanggenons from root bark for inhalation administration.

Schwarzinger J, Adelsberger S, Ortmayr K, Stellnberger S, Tahir A, Hadrich G Int J Pharm X. 2024; 8:100272.

PMID: 39252692 PMC: 11381475. DOI: 10.1016/j.ijpx.2024.100272.


Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441.

Waldrip Z, Acharya B, Armstrong D, Hanafi M, Rainwater R, Amole S Sci Rep. 2024; 14(1):19999.

PMID: 39198533 PMC: 11358143. DOI: 10.1038/s41598-024-70858-w.